Società Emergent Biosolutions Inc CINNOBER BOAT
Azioni
0IGA
US29089Q1058
Prodotti farmaceutici
Attività
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Commercial Products
47,4
%
| - | - | 497 | 47,4 % | - |
Medical Countermeasures Products
42,6
%
| - | - | 447 | 42,6 % | - |
Services
7,5
%
| - | - | 79 | 7,5 % | - |
Reconciling Items
2,5
%
| 41 | 3,7 % | 26 | 2,5 % | -36,47% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
57,9
%
| 890 | 79,4 % | 607 | 57,9 % | -31,74% |
Canada
21,4
%
| 149 | 13,3 % | 224 | 21,4 % | +50,87% |
Other
20,8
%
| 83 | 7,4 % | 218 | 20,8 % | +163,16% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Joseph Papa
CEO | Chief Executive Officer | 68 | 21/02 |
Richard Lindahl
DFI | Director of Finance/CFO | 70 | 26/03/18 |
Kelly Warfield
CTO | Chief Tech/Sci/R&D Officer | - | 17/03/23 |
Coleen Glessner
CMP | Compliance Officer | 53 | 01/03/20 |
Laura Kennedy
CMP | Compliance Officer | - | 01/09/16 |
Sharon Solomon
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/17 |
Michelle Pepin
HRO | Human Resources Officer | - | 17/03/23 |
Corporate Officer/Principal | - | - | |
Aubrey Watkins
PRN | Corporate Officer/Principal | - | - |
General Counsel | - | 01/02/09 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 01/04/22 |
Marvin White
BRD | Director/Board Member | 61 | 01/06/10 |
Louis Sullivan
BRD | Director/Board Member | 90 | 01/01/05 |
Ronald Richard
BRD | Director/Board Member | 68 | 01/01/05 |
Chairman | 80 | 01/08/04 | |
Neal Fowler
BRD | Director/Board Member | 62 | 28/09/23 |
Sujata Dayal
BRD | Director/Board Member | 61 | 15/07/22 |
Donald DeGolyer
BRD | Director/Board Member | 63 | 28/09/23 |
Kathryn Zoon
BRD | Director/Board Member | 75 | 01/10/16 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 57 990 764 | 51 406 736 ( 88,65 %) | 5 600 000 ( 9,657 %) | 88,65 % |
Coordinate società
Emergent BioSolutions, Inc.
300 Professional Drive Suite 400
20879, Gaithersburg
+240 631 3200
http://www.emergentbiosolutions.comSettore
Vendite per attività
Vendite per regione
Variaz. 1 gen. | Capi. | |
---|---|---|
+26,08% | 681 Mrd | |
+21,85% | 556 Mrd | |
-4,77% | 361 Mrd | |
+16,97% | 325 Mrd | |
+5,69% | 285 Mrd | |
+13,68% | 235 Mrd | |
+3,65% | 199 Mrd | |
-11,12% | 189 Mrd | |
-3,40% | 157 Mrd |